Abstract
In spite of having medical centers of excellence where bone marrow transplantation is performed, Brazil is a country with a high incidence of tuberculosis, with 47 cases/100,000 inhabitants, 111,000 new cases/year and with 6,000 annual deaths. So the risk hematopoietic stem cell transplant (SCT) patients are exposed to in Brazil might be higher than the risk of M. tuberculosis infection i…